Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia
This study is ongoing, but not recruiting participants.
Sponsor:
Xencor, Inc.
Information provided by (Responsible Party):
Xencor, Inc.
ClinicalTrials.gov Identifier:
NCT01161511
First received: July 8, 2010
Last updated: May 8, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2013 |
| Estimated Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |